Monterey Bio Acquisition Statistics Share Statistics Monterey Bio Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.1M Failed to Deliver (FTD) Shares 300 FTD / Avg. Volume 30K%
Short Selling Information The latest short interest is 1, so 0% of the outstanding
shares have been sold short.
Short Interest 1 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -23.7 and the forward
PE ratio is null.
Monterey Bio Acquisition's PEG ratio is
-0.02.
PE Ratio -23.7 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.53 P/FCF Ratio -30.07 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Monterey Bio Acquisition.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.23,
with a Debt / Equity ratio of 0.
Current Ratio 0.23 Quick Ratio 0.23 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 115.96K Effective Tax Rate -10.01%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Monterey Bio Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.66 200-Day Moving Average 10.45 Relative Strength Index (RSI) 16.15 Average Volume (20 Days) 1
Income Statement
Revenue n/a Gross Profit -2.04M Operating Income -2.04M Net Income -1.27M EBITDA -2.04M EBIT n/a Earnings Per Share (EPS) -0.44
Full Income Statement Balance Sheet The company has 145.81K in cash and 0 in
debt, giving a net cash position of 145.81K.
Cash & Cash Equivalents 145.81K Total Debt n/a Net Cash n/a Retained Earnings -1.86M Total Assets 22.41M Working Capital -2.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1M
and capital expenditures 0, giving a free cash flow of -1M.
Operating Cash Flow -1M Capital Expenditures n/a Free Cash Flow -1M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
